Scholarlink

Background <p>Hereditary diffuse gastric cancer (HDGC), caused by pathogenic variants (PVs) in <i>CDH1</i>, typically presents as early-stage mucosal lesions composed of non-proliferative signet ring cells (SRCs). While loss of E-cadherin initiates tumorigenesis, the somatic genetic alterations driving progression to advanced disease remain poorly understood.</p> Objective <p>Our goal was to identify morphological and genetic changes associated with HDGC progression.</p> Design <p>We performed whole exome sequencing on 38 gastric tumors from 26 HDGC patients, spanning early to advanced stages, and compared genetic alterations across tumor stages.</p> Results <p>Early-stage HDGC lesions exhibited minimal somatic alterations, with low tumor mutational burden (TMB) and few cancer-related mutations. In contrast, advanced tumors showed a significant increase in TMB and frequent somatic mutations in <i>CDH1</i>, <i>TP53</i>, and genes involved in TGF-β signaling, cell adhesion, and actomyosin contractility (e.g., <i>SMAD4</i>, <i>FAT4</i>, <i>RHOA</i>). Copy number variations (CNVs) were also more prevalent in advanced tumors, including recurrent loss of 3p and 17p and amplification of oncogenes <i>MYC</i> and <i>MET</i>. CNV profiles varied between tumor regions, indicating intratumoral heterogeneity and potential clonal evolution.</p> Conclusion <p>HDGC progression is marked by a stepwise accumulation of somatic mutations and chromosomal alterations. While early lesions remain genetically quiet, advanced tumors exhibit complex genetic landscapes, including <i>CDH1</i> inactivation, oncogenic mutations, and CNVs. These findings highlight key molecular events in HDGC progression and may inform future strategies for early detection and targeted intervention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mapping the genetic landscape of hereditary diffuse-type gastric cancer progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • Lars J. S. Kemp,
  • Remco van Cruchten,
  • Robin Lomans,
  • Natasja Rutgers,
  • Lodewijk A. A. Brosens,
  • Liudmila L. Kodach,
  • Jolanda M. van Dieren,
  • Tanya M. Bisseling,
  • Richarda de Voer,
  • Martijn Gloerich,
  • Chella R. S. van der Post

摘要

Background

Hereditary diffuse gastric cancer (HDGC), caused by pathogenic variants (PVs) in CDH1, typically presents as early-stage mucosal lesions composed of non-proliferative signet ring cells (SRCs). While loss of E-cadherin initiates tumorigenesis, the somatic genetic alterations driving progression to advanced disease remain poorly understood.

Objective

Our goal was to identify morphological and genetic changes associated with HDGC progression.

Design

We performed whole exome sequencing on 38 gastric tumors from 26 HDGC patients, spanning early to advanced stages, and compared genetic alterations across tumor stages.

Results

Early-stage HDGC lesions exhibited minimal somatic alterations, with low tumor mutational burden (TMB) and few cancer-related mutations. In contrast, advanced tumors showed a significant increase in TMB and frequent somatic mutations in CDH1, TP53, and genes involved in TGF-β signaling, cell adhesion, and actomyosin contractility (e.g., SMAD4, FAT4, RHOA). Copy number variations (CNVs) were also more prevalent in advanced tumors, including recurrent loss of 3p and 17p and amplification of oncogenes MYC and MET. CNV profiles varied between tumor regions, indicating intratumoral heterogeneity and potential clonal evolution.

Conclusion

HDGC progression is marked by a stepwise accumulation of somatic mutations and chromosomal alterations. While early lesions remain genetically quiet, advanced tumors exhibit complex genetic landscapes, including CDH1 inactivation, oncogenic mutations, and CNVs. These findings highlight key molecular events in HDGC progression and may inform future strategies for early detection and targeted intervention.